Simultaneous Dual-Gene Detection of

Detecting Escherichia coli O157:H7—a notorious foodborne pathogen linked to severe kidney failure and intestinal damage—is a race against time. Researchers have developed a single-tube test that can identify this specific bacterium by looking for two genetic markers at once. By using specialized CRISPR proteins that glow different colors (red and green) to confirm the exact serotype (a specific classification based on surface antigens), the system offers a faster, simpler alternative to the heavy laboratory equipment required by current gold standards.

The bottleneck in pathogen serotyping

Current methods for identifying E. coli O157:H7 often force a trade-off between speed and certainty. Traditional culture-based methods involve growing bacteria on selective media. These are highly reliable but require 16 to 24 hours of incubation. On the other end of the spectrum, immunoassays like ELISA can provide quicker results. However, they are prone to cross-reactivity—essentially "false alarms" caused by other bacteria that look similar to the target.

While nucleic acid-based methods like PCR (Polymerase Chain Reaction) offer high precision, they require expensive thermal cyclers. These machines rapidly heat and cool samples. This dependency on bulky hardware makes them difficult to deploy in field settings, such as a farm or a food processing plant. Furthermore, many existing CRISPR-based diagnostics struggle with "multiplexing" (the ability to detect multiple targets in one go). Because the Cas13 enzyme used in these systems tends to cut everything in its vicinity once activated, it is difficult to run two different tests in the same tube without the signals bleeding into one another.

A dual-channel CRISPR architecture

To solve the multiplexing problem, the authors report a biosensor that exploits the "personality" differences of two distinct Cas13 proteins. They leverage specific nucleotide cleavage preferences to separate the signals. Think of it like having two different locksmiths in the same room: one only works with brass keys, and the other only works with silver ones. Even if they are both active, they won't accidentally trigger each other's tools.

As illustrated in, the detection process follows four stages: target amplification, transcription (converting DNA to RNA), CRISPR recognition, and signal readout.

The researchers chose two specific genetic markers to ensure they were catching the correct serotype: the rfbEO157 gene and the fliCH7 gene.

The clever part lies in the biochemical preferences of the enzymes. The authors utilize LwaCas13a, which preferentially cleaves RNA between adenine (A) and uracil (U). They pair this with PsmCas13b, which prefers cleavage between two adenines (A-A). By matching LwaCas13a with a red-fluorescing TEX probe and PsmCas13b with a green-fluorescing FAM probe, the researchers created two independent communication channels. As shown in, when the target RNA is present, the respective Cas13 protein activates and cuts its specific probe.

This releases a colored signal. Because the enzymes ignore the "wrong" nucleotide sequences, the red and green signals do not interfere with each other.

From laboratory tubes to one-pot deployment

The transition from a complex lab protocol to a field-ready tool required moving away from PCR. Instead, the authors utilized Recombinase Polymerase Amplification (RPA), an isothermal method that works at a constant 37 °C. Unlike PCR, which requires constant temperature swings, RPA stays at a steady warmth. This makes it compatible with the delicate enzymes used in the subsequent CRISPR and transcription steps.

By combining RPA, T7 RNA polymerase (an enzyme that facilitates transcription), and the dual Cas13 channels into a single reaction vessel, the researchers created a "one-pot" system. The authors report that this streamlined approach achieves a detection limit of 54 CFU/mL (colony-forming units per milliliter). This level of sensitivity means the test can detect very low concentrations of bacteria in a sample.

To prove this wasn't just a theoretical success, the study applied the sensor to a murine (mouse) infection model. As documented in, the biosensor's ability to track bacterial shedding in fecal samples matched the results of standard PCR and qPCR (quantitative PCR) almost perfectly.

The authors found that the sensor maintained a 100% specificity rate relative to qPCR in these clinical samples. This means it did not misidentify other bacteria as the pathogen.

Constraints on the current platform

While the results are promising, the paper identifies several technical boundaries. First, the current "one-pot" system is optimized for qualitative detection—answering "is it there?"—rather than absolute quantification. Because the final brightness of the glow is affected by a complex chain of events, it is difficult to establish a stable mathematical relationship between the light intensity and the exact number of bacteria present. These events include RPA efficiency, transcription efficiency, and Cas13 activity.

Second, the multiplexing capability is currently capped at two targets. While the use of different Cas13 orthologs (variants of the enzyme) allows for separation, expanding this to a "triple" or "quadruple" test would require discovering even more enzymes with uniquely distinct cleavage signatures. Finally, the study focuses on relatively controlled biological environments. The authors note that further validation is needed to ensure the sensor performs reliably in more complex, "dirty" matrices like raw meat juices or environmental water samples.

The verdict

If you are looking for a tool to replace a centralized PCR lab in a high-throughput manufacturing setting, this is not it. However, for rapid, on-site screening in food safety and clinical surveillance, this is a significant step forward. The ability to achieve high sensitivity (54 CFU/mL) without thermal cycling equipment removes the largest barrier to decentralized pathogen testing. The technology is ready for prototyping in portable, handheld readers, provided the next generation of research can move toward standardized, quantitative measurements.

Figures from the paper